Stemline Therapeutics Inc (NASDAQ:STML)

Real-Time Quote
 -0.34 / -2.65%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on discovering, acquiring, developing and commercializing oncology therapeutics that target both cancer stem cells and tumor bulk. It currently developing two clinical stage products: SL-401 and SL-701. The lead indication for SL-401, a biologic targeted therapy is acute myeloid leukemia. The lead indications for SL-701, a therapeutic cancer vaccine comprised of synthetic peptides that correspond to specific targets, called epitopes, on cancer stem cells and tumor bulk of brain cancer, are pediatric and adult brain cancer. It also develops a broad portfolio of preclinical small molecules and antibodies for a variety of solid and hematological cancer types. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY.

Contact Information

Stemline Therapeutics, Inc.
750 Lexington Avenue
New York New York 10022
P:(646) 502-2310
Investor Relations:



Mutual fund holders41.35%
Other institutional22.03%
Individual stakeholders16.84%

Top Executives

Ivan BergsteinChairman, President & Chief Executive Officer
Kenneth HobermanChief Operating Officer & Secretary
David G. GioncoChief Accounting Officer & Vice President-Finance
Eric K. RowinskyChief Medical Officer, Head-Research & Development
Michael SzarekHead-Clinical & Regulatory Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.